Sourcing verified Semax peptide for sale requires rigorous analytical standards, batch-specific purity documentation, and confirmed endotoxin compliance. As a synthetic heptapeptide derived from adrenocorticotropic hormone (ACTH 4-10), Semax is widely evaluated in neurodevelopmental, ischemic, and neuroprotective preclinical models. PX1 Research supplies ultra-pure, USA-manufactured Semax lyophilized powder specifically intended for in vitro assays and non-human laboratory experimentation.
Sourcing verified Semax peptide for sale requires rigorous analytical standards, batch-specific purity documentation, and confirmed endotoxin compliance. As a synthetic heptapeptide derived from adrenocorticotropic hormone (ACTH 4-10), Semax is widely evaluated in neurodevelopmental, ischemic, and neuroprotective preclinical models. PX1 Research supplies ultra-pure, USA-manufactured Semax lyophilized powder specifically intended for in vitro assays and non-human laboratory experimentation.
When acquiring Semax peptide for sale for institutional or laboratory research, investigators must prioritize analytical transparency, including lot-specific High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS) verification. PX1 Research supplies high-purity (>99%) lyophilized Semax manufactured in USA-based, ISO 17025-accredited and GMP-compliant facilities, complete with published Certificates of Analysis (COAs) and LAL endotoxin testing for valid in vitro and preclinical experimentation.
Semax is a synthetic regulatory heptapeptide with the chemical sequence Met-Glu-His-Phe-Pro-Gly-Pro. It was originally synthesized by replacing the C-terminal tripeptide of adrenocorticotropic hormone fragment 4-10 (ACTH 4-10) with the tripeptide Pro-Gly-Pro. This specific modification significantly increases resistance to endopeptidases and carboxypeptidases in cell culture media and extracellular fluids, making it a primary reference compound across neurobiology, cellular biology, and electrophysiology literature. Researchers looking to expand their laboratory inventory can explore our comprehensive catalog of research peptides for additional reference compounds.
The molecular architecture of Semax (C37H51N9O10S, molecular mass approximately 810.91 g/mol) is engineered to retain the core physiological signaling capabilities of the ACTH(4-10) sequence while enhancing chemical stability. The inclusion of the C-terminal Pro-Gly-Pro sequence creates conformational constraints that impede enzymatic cleavage by circulating peptidases in preclinical models.
In analytical evaluations, pure Semax appears as a white to off-white lyophilized cake or powder. Due to its polar amino acid side chains—specifically Glutamic acid (Glu) and Histidine (His)—the molecule exhibits robust solubility in aqueous laboratory buffers, including sterile water for injection and phosphate-buffered saline (PBS). For precise quantitative assays, maintaining conformational integrity during solubilization is critical, as degraded peptide fragments can confound binding affinity assays and cellular signaling measurements.
In vitro and rodent models consistently demonstrate that Semax modulates neurotrophin synthesis and neurotrophic receptor signaling pathways. Primary among these mechanisms is the rapid upregulation of Brain-Derived Neurotrophic Factor (BDNF) expression and its corresponding tropomyosin receptor kinase B (TrkB) signaling cascade within hippocampal and cortical tissue preparations.
Preclinical studies indicate that exposure to the Semax research peptide triggers elevated mRNA transcription for both BDNF and Nerve Growth Factor (NGF). In cultured neuronal populations, this neurotrophic surge correlates with increased neurite outgrowth, enhanced synaptic density, and superior cell survival during oxidative stress or glutamate excitotoxicity assays. Investigating these cascades provides valuable insights into broader preclinical neuroprotective mechanisms under controlled laboratory conditions.
Beyond neurotrophin upregulation, published animal research highlights the capacity of Semax to influence gene expression profiles associated with vascular endothelial integrity and inflammatory responses. In rodent focal ischemia models, quantitative PCR analysis revealed that Semax administration leads to a swift downregulation of pro-inflammatory cytokines, specifically Interleukin-6 (IL-6) and Tumor Necrosis Factor-alpha (TNF-α), while modulating Vascular Endothelial Growth Factor (VEGF) pathway expression.
These regulatory actions appear to protect the structural integrity of the blood-brain barrier (BBB) microvasculature in experimental stroke models. By altering local immune gene transcription and suppressing microglial overactivation in vitro, Semax serves as a crucial molecular probe for examining ischemic injury cascades, neuroinflammation, and cerebral autoregulation.
When designing preclinical protocols focused on central nervous system targets, researchers frequently evaluate Semax alongside other synthetic regulatory peptides. A primary comparative compound is the Selank research peptide, a synthetic heptapeptide derived from human tuftsin (Thr-Lys-Pro-Arg-Pro-Gly-Pro). While Semax acts primarily via ACTH/BDNF signaling pathways to influence executive functioning and ischemic gene expression, Selank targets enkephalin degradation enzymes and GABAergic transmission, making them distinct probes for complementary neurological pathways.
Additionally, modified analogs such as N-Acetyl Semax Amidate incorporate N-terminal acetylation and C-terminal amidation to further extend systemic half-life and cross-membrane permeability in specialised tissue culture models. Evaluating these related structures alongside standard reference materials from our peptide analytical documentation hub ensures that researchers select the precise molecular tool for their target assay.
Because synthetic peptides are prone to sequence truncated impurities, deletion sequences, and residual trifluoroacetic acid (TFA) salts, acquiring high-purity Semax requires rigorous analytical verification. PX1 Research enforces multi-stage testing on every production lot. Every vial of Semax peptide for sale is analyzed using Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) to confirm a chemical purity threshold of >99%.
Electrospray Ionization Mass Spectrometry (ESI-MS) is performed simultaneously to confirm exact monoisotopic mass and verify the absence of structural isomers or un-deprotected side chain artifacts. Furthermore, because bacterial endotoxins (lipopolysaccharides) can induce non-specific inflammatory signaling in cell cultures, PX1 Research subjects all lots to Chromogenic LAL (Limulus Amebocyte Lysate) assay testing, enforcing strict limits below 0.01 EU/mg. Institutional buyers interested in high-volume orders can review bulk procurement standards on our institutional procurement and wholesale accounts page.
To preserve peptide integrity and prevent degradation, lyophilized Semax must be stored in a controlled environment upon receipt. Unopened vials should be maintained at -20°C for short-term stability or -80°C for long-term archiving. Exposure to room temperature, direct light, and ambient humidity should be strictly minimized during initial lab intake.
When preparing Semax for in vitro research, reconstitution should be performed using aseptic technique under a laminar flow hood. Reconstitute the lyophilized powder using sterile Bacteriostatic Water or cell-culture grade phosphate-buffered saline (PBS), gently swirling the vial until complete dissolution occurs. Vigorous vortexing must be avoided, as mechanical shear stress can disrupt peptide secondary structure. Once reconstituted, solution aliquots should be frozen at -20°C to eliminate repeated freeze-thaw cycles, which degrade peptide potency over time.
Procuring high-grade reference material is essential for reproducible research. PX1 Research eliminates supply chain ambiguity by manufacturing all research compounds exclusively in state-of-the-art, USA-based facilities adhering to cGMP guidelines and ISO 17025 laboratory quality management systems. Every product batch is accompanied by downloadable, lot-traceable analytical COAs.
To support fast-paced experimental timelines, PX1 Research maintains full inventory across dual fulfillment centers located in California and Arizona, providing same-day shipping on orders placed before cutoff times Monday through Friday. When sourcing your institution's Semax peptide for sale, PX1 Research offers unmatched purity, batch consistency, and dedicated technical support for biomedical investigators worldwide.
What is the sequence and chemical structure of Semax?
Semax is a synthetic heptapeptide with the amino acid sequence Met-Glu-His-Phe-Pro-Gly-Pro. It has a molecular formula of C37H51N9O10S and a molecular weight of approximately 810.91 g/mol.
Is Semax provided by PX1 Research intended for human consumption?
No. Semax supplied by PX1 Research is strictly designated for laboratory research, in vitro assays, and preclinical non-human experimentation. It is not for human or animal therapeutic, diagnostic, or clinical use.
How is the purity of Semax verified prior to distribution?
Each batch of Semax undergoes rigorous quality control, including RP-HPLC to verify purity greater than 99%, Mass Spectrometry (MS) to confirm correct molecular identity, and LAL assays to ensure strict endotoxin control.
What are the recommended long-term storage conditions for lyophilized Semax?
Lyophilized Semax powder should be stored at -20°C for short-to-medium term preservation or at -80°C for extended storage. Keep vials protected from light, moisture, and temperature fluctuations.
How should Semax be reconstituted for laboratory research assays?
Reconstitution should be conducted using sterile Bacteriostatic Water or PBS under a laminar flow hood. Gently invert or swirl the vial to dissolve the cake; do not vortex vigorously. Prepare single-use aliquots to prevent freeze-thaw degradation.
What endotoxin standard applies to PX1 Research Semax vials?
PX1 Research enforces stringent endotoxin limits, verifying that residual bacterial endotoxins remain below 0.01 EU/mg via LAL testing, ensuring compatibility with sensitive cell culture and tissue preparations.
How does Semax differ structurally from Selank?
Semax is an ACTH(4-10) derivative (Met-Glu-His-Phe-Pro-Gly-Pro), whereas Selank is derived from the immune peptide tuftsin (Thr-Lys-Pro-Arg-Pro-Gly-Pro). They target distinct neurological and biochemical receptor pathways in preclinical models.
What shipping options and fulfillment timelines are offered by PX1 Research?
PX1 Research operates dual fulfillment hubs in California and Arizona, offering same-day dispatch for orders placed before 3:00 PM EST, Monday through Friday, ensuring rapid delivery for research institutions.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.